Aroma compound

IN8bio Presents Positive Data Update from Induced Pluripotent Stem Cell (iPSC) Platform at the Society for Immunotherapy of Cancer (SITC) 38th Annual Meeting

Retrieved on: 
Friday, November 3, 2023

Our proprietary expansion methods are serum and feeder-free and have the potential to produce billions of iVδ1 T cells.

Key Points: 
  • Our proprietary expansion methods are serum and feeder-free and have the potential to produce billions of iVδ1 T cells.
  • Showcases the capability to manufacture specific gamma-delta T cell sub-types using a process that can be scaled for GMP- manufacturing as a potentially ‘off-the-shelf’ platform for allogeneic cell therapy.
  • NEW YORK, Nov. 03, 2023 (GLOBE NEWSWIRE) -- IN8bio, Inc. (Nasdaq: INAB), a leading clinical-stage biopharmaceutical company focused on innovative gamma-delta T cell therapies, today presented new positive preclinical data from its induced pluripotent stem cell (iPSC) gamma-delta T cell platform at the Society for Immunotherapy of Cancer’s (SITC) 38th Annual Meeting (Abstract #: 637 in Exhibit Halls A and B1).
  • The data represents a significant advance in the development of the INB-500 iPSC program towards the development of allogeneic gamma-delta T cell therapies.

Clean Beauty Market Set to Reach $8.10 Billion by 2023: Rising Consumer Awareness Drives Demand - ResearchAndMarkets.com

Retrieved on: 
Monday, November 6, 2023

The global clean beauty market is poised for substantial growth and is expected to reach a market value of US$8.10 billion by 2023, with a remarkable CAGR of 12.13% over the projected period.

Key Points: 
  • The global clean beauty market is poised for substantial growth and is expected to reach a market value of US$8.10 billion by 2023, with a remarkable CAGR of 12.13% over the projected period.
  • Consumers have grown more discerning about product ingredients, fueling the demand for clean beauty products.
  • Product Types: The global clean beauty market encompasses five key segments: Skin Care, Hair Care, Cosmetics, Fragrances, and Others.
  • Rising consumer awareness and a preference for clean beauty products are driving market growth.

'Tis the Season: 7-Eleven, Inc. Brews Up Holiday Cheer with New Coffee Flavors

Retrieved on: 
Thursday, November 2, 2023

IRVING, Texas, Nov. 2, 2023 /PRNewswire/ -- 7-Eleven, Inc., the OG To-Go Since 1964™ coffee destination, is getting in the holiday spirit with the introduction of new, exclusive beverage flavors just in time for the winter season, available at participating 7-Eleven®, Speedway®, and Stripes® stores across the country.

Key Points: 
  • Winter Wonderland Cocoa: This fan-favorite rich, red, hot chocolate is back – with a peppermint candy cane flavor.
  • It's holiday cheer in a cup!
  • Gingerbread Syrup: Switch up your morning coffee routine with the Gingerbrewed Latte recipe hack.
  • To sweeten the deal even more, 7Rewards® and Speedy Rewards® members can grab a large coffee for just $1.49 for a limited time.

Smells like learning

Retrieved on: 
Tuesday, October 31, 2023

They have found that certain neurons allow fruit flies and mice to tell apart distinct smells.

Key Points: 
  • They have found that certain neurons allow fruit flies and mice to tell apart distinct smells.
  • Next, the team observed that some neurons respond differently to two very dissimilar odors, but the same to similar smells.
  • Another much larger group of neurons responds unpredictably when exposed to similar smells.
  • In more continual learning systems, variability could be useful."

Celebrate The Holidays with Personalized Gifts from Katie Loxton's Newly Released Christmas Collection

Retrieved on: 
Friday, October 27, 2023

NEW YORK, Oct. 27, 2023 /PRNewswire-PRWeb/ -- Katie Loxton, the esteemed British accessories and lifestyle brand renowned as the ultimate destination for gifting and personalization, is thrilled to announce the launch of its Christmas Collection, just in time for the festive season. With a legacy of accessible luxury and tasteful personalization, Katie Loxton's Christmas Collection is a meticulously curated assortment designed to cater to a diverse audience. This festive lineup introduces captivating new features, including enchanting starburst print packaging and an array of seasonal colorways such as Emerald Green, Ice Blue, Cool Gray, and Eggshell. From festive Fragrances, cozy Scarves, and giftable products to the option of personalization across a selection of their best-selling bags and accessories, this collection offers something special for everyone. Thoughtfully designed with friends, family, colleagues, and more in mind, it provides a treasure trove of enchanting, personalized gifts for this winter season. Whether customers seek vegan leather pouches, crossbody, shoulder, and duffel bags, and accessories or the warm ambiance of home fragrances and candles, Katie Loxton's latest collection ensures a joyful and stylish holiday.

Key Points: 
  • Katie Loxton, the British accessories brand, has unveiled its Christmas Collection, featuring personalized gifts, festive candles, scarves, and chic bags in a variety of elegant designs and seasonal colors.
  • With a legacy of accessible luxury and tasteful personalization, Katie Loxton's Christmas Collection is a meticulously curated assortment designed to cater to a diverse audience.
  • Thoughtfully designed with friends, family, colleagues, and more in mind, it provides a treasure trove of enchanting, personalized gifts for this winter season.
  • From October 27th to 31st you can get ahead of holiday shopping and secure beautiful gifts from Katie Loxton's Christmas Collection and more.

Wildway Embarks on a Transformative Journey Towards Regenerative Agriculture with Planet Friendly Oats

Retrieved on: 
Thursday, October 26, 2023

Wildway believes that food is not just sustenance; it's an avenue for positive change.

Key Points: 
  • Wildway believes that food is not just sustenance; it's an avenue for positive change.
  • By continually pushing the boundaries, Wildway is shaping a food future prioritizing regeneration over mere sustainability.
  • "At Wildway, we've embraced a new chapter in our commitment to food as an avenue for positive change," said Kyle Koehler, CEO and co-founder at Wildway.
  • We're excited to be at the forefront of this transformative journey, emphasizing our responsibility to both our consumers and the vitality of regenerative farming."

How do stimulants actually work to reduce ADHD symptoms?

Retrieved on: 
Friday, October 27, 2023

Stimulants are first-line drugs for children and adults diagnosed with attention-deficit hyperactivity disorder (ADHD). But how do they actually work?First, let’s look at the brainMedical imaging indicates people with ADHD may have slight differences in their brain’s structure, the way their brain regions work together to perform tasks, and how their brain’s chemical messengers, called neurotransmitters, pass on information.

Key Points: 


Stimulants are first-line drugs for children and adults diagnosed with attention-deficit hyperactivity disorder (ADHD). But how do they actually work?

First, let’s look at the brain

  • Medical imaging indicates people with ADHD may have slight differences in their brain’s structure, the way their brain regions work together to perform tasks, and how their brain’s chemical messengers, called neurotransmitters, pass on information.
  • These brain differences are associated with the symptoms of ADHD, including inattention, impulse control and problems with memory.

What stimulants are prescribed in Australia?

  • The three main stimulants prescribed for ADHD in Australia are dexamfetamine, methylphenidate (sold under the brand names Ritalin and Concerta) and lisdexamfetamine (sold as Vyvanse).
  • Dexamfetamine and methylphenidate have been around since the 1930s and 1940s respectively.

So how do they work for ADHD?

  • Stimulants increase the amount of dopamine and noradrenaline in the tiny gaps between neurons, known as synapses.
  • They do this by predominantly blocking a transporter that then prevents their re-uptake back into the neuron that released them.
  • Amphetamines also increase the amount of dopamine the neuron releases into the synapse (the tiny gaps between neurons).

What effect do they have on ADHD symptoms?


We still don’t fully understand the underlying brain mechanisms that change behaviour in people with ADHD. But research shows stimulants that modulate noradrenaline and dopamine can improve brain processes such as:
They can also improve general behaviour, such as self-control, not talking over the top of others, and concentration. These behaviours are important for social interactions. Stimulants reduce ADHD symptoms in about 70% to 80% of children and adults who take them. Some people will notice their symptoms improve right away. Other times, these improvements will be more noticeable to parents, carers, teachers, colleagues and partners.

Not everyone gets the same dose


The optimal stimulant dose varies between individuals, with multiple dosage options available. This enables a “start low, go slow” approach, where the stimulant can be gradually increased to the most effective dose for the individual.

  • Dexamfetamine and methylphenidate are available in immediate-release preparations.
  • As these have short half-lives (meaning they act quickly and wear off rapidly), they are often taken multiple times a day – usually in the morning, lunch and afternoon.
  • Methylphenidate is also available in long-acting tablets (Concerta) and capsules (Ritalin LA).

What are the side effects?


The most common side effects are sleep problems and decreased appetite. A recent study showed children and young people taking methylphenidate for ADHD were around 2.6 times more likely to have sleep problems and 15 times more likely to have a decreased appetite than those not taking methylphenidate. Headache and abdominal pain are also relatively common.

Can someone without ADHD take a stimulant to improve productivity?

  • As stimulants increase dopamine, they can cause euphoria and a heightened sense of wellbeing.
  • A common myth about stimulant medicines is they can improve the concentration and productivity of people without ADHD.
  • At each of the sessions, participants were given either a placebo or a stimulant before completing the task.
  • Read more:
    ADHD medications have doubled in the last decade – but other treatments can help too


Mary Bushell does not work for, consult, own shares in or receive funding from any company or organisation that would benefit from this article, and has disclosed no relevant affiliations beyond their academic appointment.

Hand Sanitizers Market Set to Skyrocket to $66.3 Billion by 2030, Driven by an 11.9% CAGR - ResearchAndMarkets.com

Retrieved on: 
Thursday, October 26, 2023

Aging Population and their Vulnerability to Various Infections: A Major Growth Driver

Key Points: 
  • Aging Population and their Vulnerability to Various Infections: A Major Growth Driver
    Global Aging Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
    Fragrance to Become an Important Attribute of Hand Sanitizers, Bodes Well for the Market
    Global Sanitizer Sale by Distribution Channel: 2019

A large international study of migraine reveals new biological pathways for treatment

Retrieved on: 
Thursday, October 26, 2023

The scientists focused on detecting sequence variants associated with the the two main subtypes of migraine: migraine with aura (often referred to as classical migraine) and migraine without aura.

Key Points: 
  • The scientists focused on detecting sequence variants associated with the the two main subtypes of migraine: migraine with aura (often referred to as classical migraine) and migraine without aura.
  • The results highlight several genes that affect one of these migraine subtypes over the other, and point to new biological pathways that could be targeted for therapeutic developments.
  • Four novel migraine with aura associations were revealed and 13 variants associated primarily with migraine without aura.
  • Of particular interest were three rare variants with large effects pointing to distinct pathologies underlying different types of migraine.

A large international study of migraine reveals new biological pathways for treatment

Retrieved on: 
Thursday, October 26, 2023

The scientists focused on detecting sequence variants associated with the the two main subtypes of migraine: migraine with aura (often referred to as classical migraine) and migraine without aura.

Key Points: 
  • The scientists focused on detecting sequence variants associated with the the two main subtypes of migraine: migraine with aura (often referred to as classical migraine) and migraine without aura.
  • The results highlight several genes that affect one of these migraine subtypes over the other, and point to new biological pathways that could be targeted for therapeutic developments.
  • Four novel migraine with aura associations were revealed and 13 variants associated primarily with migraine without aura.
  • Of particular interest were three rare variants with large effects pointing to distinct pathologies underlying different types of migraine.